Skip to content
Nonprofiteer
← All organizations

GABRIELLES ANGEL FOUNDATION FOR CANCER RESEARCH INC

EIN 13-3916689 NEW YORK, NY

Revenue 2024
$2,201,642
Expenses 2024
$2,444,810

Program services were 87.1% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

As filed

Subsection
03
NTEE code
T22
Classification
1000
Street
430 W 14TH STREET

These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).

Mission and programs · 2024

Mission

THE PURPOSE OF GABRIELLE'S ANGEL FOUNDATION FOR CANCER RESEARCH, INC. (THE "FOUNDATION") IS TO ENCOURAGE THE DEVELOPMENT OF MORE EFFECTIVE THERAPIES FOR PATIENTS WITH LEUKEMIA, LYMPHOMA AND RELATED CANCERS. THE FOUNDATION FUNDS INNOVATIVE CLINICAL OR BASIC SCIENCE RESEARCH THAT WILL LEAD TO NOVEL THERAPEUTIC APPROACHES THAT COULD REPLACE, OR BE USED IN COMBINATION WITH, EXISTING EFFECTIVE THERAPIES. SUCH THERAPEUTIC APPROACHES COULD INCLUDE INTEGRATIVE (INTEGRATIVE / COMPLEMENTARY) MEDICINE. THE FOUNDATION FUNDS RESEARCH TO IMPROVE THE EFFICENCY OF CANCER TREATMENTS, REDUCE THEIR TOXICITY AND IMPROVE THE QUALITY OF LIFE OF PATIENTS WITH LEUKEMIA OR LYMPHOMA. THE FOUNDATION ALSO SUPPORTS LIMITED SCIENTIFIC INTERCHANGE BETWEEN SELECT LEADERS IN DIFFERENT AREAS OF BIO AND INTEGRATIVE MEDICAL RESEARCH TO DEVELOP UNIQUE AND IMPORTANT COLLABORATIVE EFFORTS THAT WILL LEAD TO IMPROVEMENTS IN THE TREATMENT AND CARE OF PATIENTS WITH LEUKEMIA AND LYMPHOMA.

Activities or mission (Part I)

TO ENCOURAGE THE DEVELOPMENT OF MORE EFFECTIVE THERAPIES FOR PATIENTS WITH LEUKEMIA, LYMPHOMA

  • FOUNDATION FUNDS INNOVATIVE CLINICAL OR BASIC SCIENCE RESEARCH THAT WILL LEAD TO NOVEL THERAPEUTIC APPROACHES THAT COULD REPLACE, OR BE USED IN COMBINATION WITH EXISTING EFFECTIVE THERAPIES FOR PATIENTS WITH LEUKEMIA, LYMPHOMA AND RELATED CANCERS.

    Expenses $2,128,229 · Grants $1,520,750

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Officers and directors · 2024

As listed in Part VII of the 2024 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.

  • DENISE RICH

    PRESIDENT & CO-FOUNDER

    Total calculated
    $0
    Hours/week
    3

  • MICHELE RELLA

    TREASURER

    Total calculated
    $0
    Hours/week
    3

  • DANIELLA RICH KILSTOCK

    DIRECTOR

    Total calculated
    $0
    Hours/week
    3

  • ILONA RICH SCHACHTER

    DIRECTOR

    Total calculated
    $0
    Hours/week
    3

  • STEPHEN D NIMER MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    3

  • STAR JONES

    DIRECTOR

    Total calculated
    $0
    Hours/week
    3

  • PATRICIA QUICK

    DIRECTOR

    Total calculated
    $0
    Hours/week
    3

  • PAUL SCHINDLER ESQ

    DIRECTOR

    Total calculated
    $0
    Hours/week
    3

  • LORRAINE ESCHWARTZ

    DIRECTOR

    Total calculated
    $0
    Hours/week
    3

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. Earlier years are each on their own filing page.

Filings

  • 2024
    Revenue
    $2,201,642
    Expenses
    $2,444,810
    Contributions
    $1,981,825
    Grants paid
    $1,520,750
  • 2023
    Revenue
    $3,625,026
    Expenses
    $3,622,772
    Contributions
    $3,504,879
    Grants paid
    $2,703,500
  • 2022
    Revenue
    $2,464,150
    Expenses
    $1,897,102
    Contributions
    $2,578,537
    Grants paid
    $1,180,500

The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.

Other returns filed

  • 2021 · 990

    Revenue
    $2,400,812
    Expenses
    $2,727,907
    Assets (EOY)
    $5,237,050

  • 2020 · 990

    Revenue
    $1,122,508
    Expenses
    $2,200,110
    Assets (EOY)
    $4,721,277

  • 2019 · 990

    Revenue
    $3,131,288
    Expenses
    $2,031,721
    Assets (EOY)
    $5,964,326

  • 2018 · 990

    Revenue
    $2,510,040
    Expenses
    $2,961,377
    Assets (EOY)
    $5,333,248

Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all.

Grants made

The 10 largest by cash amount. The API serves every itemized grant.

Where these grants went next →

Grants received

The 10 largest by cash amount. The API serves every itemized grant.

Other IRS files

Auto-Revocation List

Not listed. The IRS publishes this list for organizations whose exemption was automatically revoked for failing to file for three consecutive years.

Publication 78

Listed as of 13 October 2026, under deductibility PC.

These are two separate IRS files on two separate schedules, shown as published and not reconciled with each other. Neither is a statement about whether a contribution is deductible today: 19,245 organizations appear in Publication 78 while the IRS's own revocation file lists them as currently revoked, more than half of those revoked before 2019. Absence from Publication 78 is evidence of nothing, and presence is not evidence either. Verify current status with the IRS before relying on it.

What this page reflects

The registration facts above come from the IRS Business Master File published 13 October 2026 and read 26 October 2026, for every organization at once. Returns through tax year 2024, the newest we have parsed for this organization.